Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...
InvestorsHub on MSN
Royalty Pharma signs $500M co-development agreement with J&J
Royalty Pharma plc (NASDAQ:RPRX) said it has entered into a research and development co-funding agreement with Johnson & ...
Royalty Pharma plc (Nasdaq: RPRX) today announced a research and development (R&D) co-funding agreement with Johnson & Johnson for a total of $500 million in 2026 and 2027 to advance the development ...
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate of ...
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected ...
Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 ...
Royalty Pharma said on Monday it has signed a $500 million research and development agreement with Johnson & Johnson to ...
Pharmaceutical giant Takeda is shutting down its research and development hub in San Diego that employs 324 as part of a broader restructuring of the business. “This site closure is primarily a result ...
The positions in the table below reflect the National Laboratory of Pharmaceutical Research and Development’s (PharmaLab)'s position overall, domestically, within their sector, and in various subject ...
First-of-its-kind program in North Texas to train future leaders in drug discovery and development.Applications for the new Ph.D. in Pharmaceutical Sciences deg ...
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Article ‘Count’ and ‘Share’ for National Laboratory of Pharmaceutical Research and Development’s (PharmaLab) based on listed parameters only. The articles listed below published by authors from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results